Publications by authors named "Alan Lamont"

Claim this Profile
E
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.
Gordon J S Rustin, Maria E L van der Burg, Clare L Griffin, David Guthrie, Alan Lamont

Lancet· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.
Ian A Cree, Christian M Kurbacher, Alan Lamont, Andrew C Hindley, Sharon Love

Anticancer Drugs· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Service delivery should be funded centrally.
Bruce Sizer, Philip Murray, Alan Lamont

BMJ· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of imatinib mesylate (Glivec) on human tumor-derived cells.
Louise A Knight, Federica Di Nicolantonio, Pauline A Whitehouse, Stuart J Mercer, Sanjay Sharma, Alan Lamont

Anticancer Drugs· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer cell adaptation to chemotherapy.
Federica Di Nicolantonio, Stuart J Mercer, Louise A Knight, Francis G Gabriel, Pauline A Whitehouse, Alan Lamont

BMC Cancer· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma.
Sanjay Sharma, Michael H Neale, Federica Di Nicolantonio, Louise A Knight, Pauline A Whitehouse, Alan Lamont

BMC Cancer· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer.
Frances A Shepherd, Giuseppe Giaccone, Lesley Seymour, Channa Debruyne, Andrea Bezjak, Alan Lamont

J Clin Oncol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of an ATP-based chemosensitivity assay to design new combinations of high-concentration doxorubicin with other drugs for recurrent ovarian cancer.
Federica Di Nicolantonio, Michael H Neale, Louise A Knight, Alan Lamont, Geraldine E Skailes

Anticancer Drugs· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis